Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis
- PMID: 11891037
- DOI: 10.1016/s0169-5002(01)00475-5
Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis
Abstract
Talc pleurodesis is an effective technique for the management of symptomatic malignant pleural effusions. It is assumed that a good dispersion of talc suspension contributes to the final success of this treatment. For this purpose, guidelines often advise to rotate the patient after intra-pleural instillation of the sclerosant. This prospective, randomized study analyses the dispersion of talc suspension and the overall success rate in patients with malignant effusions. After instillation of 99mTc-sestamibi-labeled talc suspension ten subjects were rotated for 1 h, while the ten other patients remained in a stable supine body position. Scintigraphic imaging was done in two directions immediately after instillation and after 1 h with a clamped drain. The overall success of the treatment was assessed 1 month after the pleurodesis. The dispersion of talc was limited and unequal in 75% of the subjects. In two patients with apparently good distribution on anterior views, the lateral views of the scintigraphy showed only limited distribution. Rotation of the patients did not influence the dispersion of sludge after 1 min or 1 h. Pleurodesis was successful in 85% of the patients after 1-month follow-up. Standard rotation protocols for patients with malignant pleural effusion do not affect the overall dispersion of talc suspension and should be abolished because of the discomfort caused to the patients.
Similar articles
-
Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.J BUON. 2006 Oct-Dec;11(4):463-7. J BUON. 2006. PMID: 17309178
-
[The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].Zentralbl Chir. 2010 Feb;135(1):54-8. doi: 10.1055/s-0029-1224646. Epub 2009 Dec 22. Zentralbl Chir. 2010. PMID: 20029741 German.
-
[Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Dec 18;40(6):600-2. Beijing Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 19088831 Chinese.
-
Comparing approaches to the management of malignant pleural effusions.Expert Rev Respir Med. 2017 Apr;11(4):273-284. doi: 10.1080/17476348.2017.1300532. Epub 2017 Mar 8. Expert Rev Respir Med. 2017. PMID: 28271728 Review.
-
Pleurodesis for malignant pleural effusions: current controversies and variations in practices.Curr Opin Pulm Med. 2004 Jul;10(4):305-10. doi: 10.1097/01.mcp.0000129756.87090.55. Curr Opin Pulm Med. 2004. PMID: 15220757 Review.
Cited by
-
Diagnosis and management of malignant pleural effusions: state of the art in 2017.J Thorac Dis. 2017 Sep;9(Suppl 10):S1111-S1122. doi: 10.21037/jtd.2017.07.79. J Thorac Dis. 2017. PMID: 29214068 Free PMC article. Review.
-
Interventional pulmonologist perspective: treatment of malignant pleural effusion.Curr Treat Options Oncol. 2014 Dec;15(4):625-43. doi: 10.1007/s11864-014-0312-6. Curr Treat Options Oncol. 2014. PMID: 25240411 Review.
-
Management of pleural effusion, empyema, and lung abscess.Semin Intervent Radiol. 2011 Mar;28(1):75-86. doi: 10.1055/s-0031-1273942. Semin Intervent Radiol. 2011. PMID: 22379278 Free PMC article.
-
Malignant Pleural Effusion: Diagnosis and Management.Can Respir J. 2020 Sep 23;2020:2950751. doi: 10.1155/2020/2950751. eCollection 2020. Can Respir J. 2020. PMID: 33273991 Free PMC article. Review.
-
Interventions for the management of malignant pleural effusions: a network meta-analysis.Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3. Cochrane Database Syst Rev. 2020. PMID: 32315458 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources